Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
J Med Microbiol ; 67(9): 1348-1350, 2018 Sep.
Article in English | MEDLINE | ID: mdl-30051803

ABSTRACT

Mycoplasma amphoriforme is a species closely related to Mycoplasma pneumoniae, thus far with unknown clinical impact. The application of optimized diagnostics, better capable of differentiating between these two micro-organisms, identified a significant patient population positive for M. amphoriforme. The PCR designed by Ling et al. was used on respiratory samples that originally tested positive for M. pneumoniae (n=78), and identified 29 retrospectively as M. amphoriforme. The aim of this study is to describe and compare both groups. The group infected with M. amphoriforme was significantly older and more frequently had a co-infection (19 % vs 62 %), COPD and less fever. This could suggest that M. amphoriforme has opportunistic characteristics.


Subject(s)
Mycoplasma Infections/microbiology , Mycoplasma pneumoniae/isolation & purification , Mycoplasma/isolation & purification , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Female , Hospitals , Humans , Male , Middle Aged , Mycoplasma/genetics , Mycoplasma/physiology , Mycoplasma pneumoniae/genetics , Mycoplasma pneumoniae/physiology , Netherlands , Polymerase Chain Reaction , Retrospective Studies , Young Adult
2.
Lancet Infect Dis ; 17(10): 1033-1041, 2017 10.
Article in English | MEDLINE | ID: mdl-28711585

ABSTRACT

BACKGROUND: Since 2013, over 100 cases of Mycobacterium chimaera prosthetic valve endocarditis and disseminated disease were notified in Europe and the USA, linked to contaminated heater-cooler units (HCUs) used during cardiac surgery. We did a molecular epidemiological investigation to establish the source of these patients' disease. METHODS: We included 24 M chimaera isolates from 21 cardiac surgery-related patients in Switzerland, Germany, the Netherlands, and the UK, 218 M chimaera isolates from various types of HCUs in hospitals, from LivaNova (formerly Sorin; London, UK) and Maquet (Rastatt, Germany) brand HCU production sites, and unrelated environmental sources and patients, as well as eight Mycobacterium intracellulare isolates. Isolates were analysed by next-generation whole-genome sequencing using Illumina and Pacific Biosciences technologies, and compared with published M chimaera genomes. FINDINGS: Phylogenetic analysis based on whole-genome sequencing of 250 isolates revealed two major M chimaera groups. Cardiac surgery-related patient isolates were all classified into group 1, in which all, except one, formed a distinct subgroup. This subgroup also comprised isolates from 11 cardiac surgery-related patients reported from the USA, most isolates from LivaNova HCUs, and one from their production site. Isolates from other HCUs and unrelated patients were more widely distributed in the phylogenetic tree. INTERPRETATION: HCU contamination with M chimaera at the LivaNova factory seems a likely source for cardiothoracic surgery-related severe M chimaera infections diagnosed in Switzerland, Germany, the Netherlands, the UK, the USA, and Australia. Protective measures and heightened clinician awareness are essential to guarantee patient safety. FUNDING: Partly funded by the EU Horizon 2020 programme, its FP7 programme, the German Center for Infection Research (DZIF), the Swiss National Science Foundation, the Swiss Federal Office of Public Health, and National Institute of Health Research Oxford Health Protection Research Units on Healthcare Associated Infection and Antimicrobial Resistance.


Subject(s)
Cardiac Surgical Procedures/adverse effects , Heart Valve Prosthesis/adverse effects , Mycobacterium Infections/epidemiology , Mycobacterium Infections/microbiology , Mycobacterium/isolation & purification , Prosthesis-Related Infections/microbiology , Equipment Contamination , Global Health , Humans , Iatrogenic Disease , Mycobacterium/genetics , Polymorphism, Single Nucleotide , Prosthesis-Related Infections/epidemiology
3.
Mycoses ; 59(2): 101-7, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26648179

ABSTRACT

A survey of diagnosis and treatment of invasive aspergillosis was conducted in eight University Medical Centers (UMCs) and eight non-academic teaching hospitals in the Netherlands. Against a background of emerging azole resistance in Aspergillus fumigatus routine resistance screening of clinical isolates was performed primarily in the UMCs. Azole resistance rates at the hospital level varied between 5% and 10%, although rates up to 30% were reported in high-risk wards. Voriconazole remained first choice for invasive aspergillosis in 13 out of 16 hospitals. In documented azole resistance 14 out of 16 centres treated patients with liposomal amphotericin B.


Subject(s)
Amphotericin B/therapeutic use , Aspergillosis/diagnosis , Aspergillosis/drug therapy , Aspergillus fumigatus/drug effects , Voriconazole/therapeutic use , Antifungal Agents/therapeutic use , Aspergillosis/epidemiology , Aspergillus fumigatus/isolation & purification , Drug Resistance, Fungal , Humans , Netherlands/epidemiology , Surveys and Questionnaires , Voriconazole/pharmacology
4.
Eur Heart J ; 36(40): 2745-53, 2015 Oct 21.
Article in English | MEDLINE | ID: mdl-26188001

ABSTRACT

AIMS: We identified 10 patients with disseminated Mycobacterium chimaera infections subsequent to open-heart surgery at three European Hospitals. Infections originated from the heater-cooler unit of the heart-lung machine. Here we describe clinical aspects and treatment course of this novel clinical entity. METHODS AND RESULTS: Interdisciplinary care and follow-up of all patients was documented by the study team. Patients' characteristics, clinical manifestations, microbiological findings, and therapeutic measures including surgical reinterventions were reviewed and treatment outcomes are described. The 10 patients comprise a 1-year-old child and nine adults with a median age of 61 years (range 36-76 years). The median duration from cardiac surgery to diagnosis was 21 (range 5-40) months. All patients had prosthetic material-associated infections with either prosthetic valve endocarditis, aortic graft infection, myocarditis, or infection of the prosthetic material following banding of the pulmonary artery. Extracardiac manifestations preceded cardiovascular disease in some cases. Despite targeted antimicrobial therapy, M. chimaera infection required cardiosurgical reinterventions in eight patients. Six out of 10 patients experienced breakthrough infections, of which four were fatal. Three patients are in a post-treatment monitoring period. CONCLUSION: Healthcare-associated infections due to M. chimaera occurred in patients subsequent to cardiac surgery with extracorporeal circulation and implantation of prosthetic material. Infections became clinically apparent after a time lag of months to years. Mycobacterium chimaera infections are easily missed by routine bacterial diagnostics and outcome is poor despite long-term antimycobacterial therapy, probably because biofilm formation hinders eradication of pathogens.


Subject(s)
Coronary Artery Bypass/adverse effects , Cross Infection/etiology , Endocarditis, Bacterial/etiology , Heart Valve Prosthesis/adverse effects , Mycobacterium Infections, Nontuberculous/etiology , Prosthesis-Related Infections/etiology , Adult , Aged , Aortic Valve/surgery , Equipment Contamination , Female , Humans , Infant , Male , Middle Aged
5.
Respiration ; 89(6): 565-71, 2015.
Article in English | MEDLINE | ID: mdl-25925975

ABSTRACT

BACKGROUND: An outbreak of Stenotrophomonas maltophilia was observed in the cultures of bronchial aspirations. After systematic culturing of the scopes and reprocessing the equipment, it turned out to be a pseudo-outbreak caused by a failure of the disinfector to sterilize ultrasound scopes, subsequently resulting in cross infection of the bronchoscopes via the connecting tubes in the dryer. OBJECTIVES: To support the above-mentioned findings and to show how different variables influence the decontamination process. METHODS: The ultrasound scopes were deliberately contaminated with test soil and subsequently disinfected with peracetic acid (PAA), glutaraldehyde (GA) and hot water. Cultures were taken immediately after disinfection and after 4 days in the drying cabinet. RESULTS: After disinfection with PAA, persistent contamination was observed in the endobronchial ultrasound scope, and after disinfection with PAA and prolonged storage in the drying cabinet, contamination of the endoscopic ultrasound scope persisted. All ultrasound scopes were effectively disinfected with GA. CONCLUSION: It is concluded that disinfection with PAA fails to decontaminate the small channels of the ultrasound scopes. Prolonged storage in humid conditions seems to enhance the outgrowth of microorganisms. By reassignment of all endoscopes to fixed locations in the drying cabinet, by using disposable connector tubes for the balloon channels, and by using GA instead of PAA, the reprocessing procedure in our hospital was corrected effectively.


Subject(s)
Bronchoscopes/microbiology , Disease Outbreaks , Disinfectants , Endosonography/instrumentation , Equipment Contamination , Glutaral , Peracetic Acid , Stenotrophomonas maltophilia/isolation & purification , Decontamination , Gram-Negative Bacterial Infections/epidemiology , Hot Temperature , Humans , Water
6.
Ned Tijdschr Geneeskd ; 159: A8187, 2015.
Article in Dutch | MEDLINE | ID: mdl-25873217

ABSTRACT

BACKGROUND: Encephalitis caused by a free-living amoeba is relatively rare and usually fatal. This is because the diagnosis is often made late and treatment is difficult. CASE DESCRIPTION: A 41-year-old patient with a previous history including kidney transplant was admitted with clinical symptoms of encephalitis. Brain imaging showed a number of hypodense regions, which were possibly abscesses. Although an infectious cause seemed probable, even the most extensive antimicrobial treatment was ineffective. The cause was not found until 2 months after the patient's death: infection with Balamuthia mandrillaris. A PCR test was used to detect this amoeba. CONCLUSION: This case study describes the first patient in the Netherlands to be diagnosed with granulomatous amoebic encephalitis caused by B. mandrillaris. An amoeba may be the cause of encephalitis with either a fulminant course or with a gradual increase of symptoms, without conventional anti-infective therapy being effective.


Subject(s)
Amebiasis/diagnosis , Amoeba/isolation & purification , Encephalitis/diagnosis , Adult , Animals , Anti-Infective Agents/therapeutic use , Encephalitis/parasitology , Fatal Outcome , Humans , Male , Netherlands , Polymerase Chain Reaction
7.
Trials ; 16: 108, 2015 Mar 22.
Article in English | MEDLINE | ID: mdl-25872590

ABSTRACT

BACKGROUND: In a sham-controlled double-blind trial, we aim to establish the efficacy and safety of the local application of laser therapy in patients with diabetes, onychomycosis and risk factors for diabetes-related foot complications. Onychomycosis leads to thickened and distorted nails, which in turn lead to increased local pressure. The combination of onychomycosis and neuropathy or peripheral arterial disease (PAD) increases the risk of developing diabetes-related foot complications. Usual care for high-risk patients with diabetes and onychomycosis is completely symptomatic with frequent shaving and clipping of the nails. No effective curative local therapies exist, and systemic agents are often withheld due to concerns for side effects and interactions. METHODS/DESIGN: The primary aim is to evaluate the efficacy of four sessions of Nd:YAG 1064 nM laser application on the one-year clinical and microbiological cure rate in a randomized, double-blind, sham-controlled design with blinded outcome assessment. Mandatory inclusion criteria are diagnosis of diabetes, risk factors for developing foot ulcers defined as a modified Simm's classification score 1 or 2 and either neuropathy or PAD. A total of 64 patients are randomized to intervention or sham treatment performed by a podiatrist. DISCUSSION: This study will be the first double-blind study that investigates the effects of local laser therapy on onychomycosis, specifically performed in patients with diabetes with additional risk factors for foot complications. TRIAL REGISTRATION: Clinical trials.gov as NCT01996995 , first received 22 November 2013.


Subject(s)
Diabetes Mellitus, Type 1/complications , Diabetes Mellitus, Type 2/complications , Diabetic Foot/prevention & control , Foot Dermatoses/surgery , Laser Therapy , Onychomycosis/surgery , Clinical Protocols , Diabetes Mellitus, Type 1/diagnosis , Diabetes Mellitus, Type 2/diagnosis , Diabetic Foot/etiology , Double-Blind Method , Foot Dermatoses/diagnosis , Foot Dermatoses/microbiology , Humans , Laser Therapy/adverse effects , Laser Therapy/instrumentation , Lasers, Solid-State , Netherlands , Onychomycosis/diagnosis , Onychomycosis/microbiology , Research Design , Risk Factors , Time Factors , Treatment Outcome
9.
BMC Med Inform Decis Mak ; 11: 19, 2011 Mar 30.
Article in English | MEDLINE | ID: mdl-21447199

ABSTRACT

BACKGROUND: Clinicians view the accuracy of test results and the turnaround time as the two most important service aspects of the clinical microbiology laboratory. Because of the time needed for the culturing of infectious agents, final hardcopy culture results will often be available too late to have a significant impact on early antimicrobial therapy decisions, vital in infectious disease management. The clinical microbiologist therefore reports to the clinician clinically relevant preliminary results at any moment during the diagnostic process, mostly by telephone. Telephone reporting is error prone, however. Electronic reporting of culture results instead of reporting on paper may shorten the turnaround time and may ensure correct communication of results. The purpose of this study was to assess the impact of the implementation of electronic reporting of final microbiology results on medical decision making. METHODS: In a pre- and post-interview study using a semi-structured design we asked medical specialists in our hospital about their use and appreciation of clinical microbiology results reporting before and after the implementation of an electronic reporting system. RESULTS: Electronic reporting was highly appreciated by all interviewed clinicians. Major advantages were reduction of hardcopy handling and the possibility to review results in relation to other patient data. Use and meaning of microbiology reports differ significantly between medical specialties. Most clinicians need preliminary results for therapy decisions quickly. Therefore, after the implementation of electronic reporting, telephone consultation between clinician and microbiologist remained the key means of communication. CONCLUSIONS: Overall, electronic reporting increased the workflow efficiency of the medical specialists, but did not have an impact on their decision-making.


Subject(s)
Clinical Laboratory Information Systems , Infections/diagnosis , Electronic Health Records/standards , Humans , Interviews as Topic , Medicine
13.
J Clin Microbiol ; 42(1): 7-11, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14715724

ABSTRACT

Inoculation of an automated system for rapid identification (ID) and antimicrobial susceptibility testing (AST) directly from positive blood culture bottles will reduce the turnaround time of laboratory diagnosis of septicemic patients, which benefits clinical outcome and decreases patient costs. Direct test results, however, must always be confirmed by testing a pure overnight culture, which is the "gold standard." We studied the accuracy of direct testing versus repeat testing in order to investigate the possibility of refraining from repeat testing. We also assessed the clinical risk of reporting results based on direct testing only. We inoculated Vitek 2 (bioMérieux) directly from 410 positive BACTEC 9240 (BD) blood culture bottles containing gram-negative rods and studied the ID and AST results. In a comparison of direct inoculation with the standard method, a total of 344 isolates of Enterobacteriaceae and Pseudomonas aeruginosa were tested, and 93.0% were correctly identified. Of the 39 (10.2%) samples that contained bacilli not identifiable by Vitek 2, only 1 gave a conclusive, correct result. The overall MIC agreement among 312 isolates was 99.2%, with 0.8% very major and 0.02% major error rates. Of only three (polymicrobial) samples, the direct susceptibility pattern would be reported to the clinician as too sensitive. Vitek 2 results obtained from direct inoculation of blood culture bottles containing gram-negative bacilli are safe enough for immediate reporting, provided that ID and AST are consistent. Repeat testing is not necessary, unless Gram stain or overnight subculture results raise doubt about the purity of the culture.


Subject(s)
Bacteremia/microbiology , Enterobacteriaceae/drug effects , Microbial Sensitivity Tests/methods , Pseudomonas aeruginosa/drug effects , Humans
14.
Emerg Infect Dis ; 10(12): 2235-7, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15663871

ABSTRACT

Methicillin-resistant Staphylococcus aureus (MRSA) was cultured from the nose of a healthy dog whose owner was colonized with MRSA while she worked in a Dutch nursing home. Pulsed-field gel electrophoresis and typing of the staphylococcal chromosome cassette mec (SCCmec) region showed that both MRSA strains were identical.


Subject(s)
Carrier State/transmission , Dog Diseases/transmission , Methicillin Resistance/genetics , Staphylococcal Infections/transmission , Staphylococcus aureus/isolation & purification , Zoonoses , Adult , Animals , Carrier State/veterinary , Dog Diseases/microbiology , Dogs , Female , Humans , Infant , Male , Staphylococcal Infections/veterinary , Staphylococcus aureus/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...